These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7008592)
1. Immunization against nosocomial infection. Braude AI; Ziegler EJ; McCutchan JA; Douglas H Am J Med; 1981 Feb; 70(2):463-6. PubMed ID: 7008592 [TBL] [Abstract][Full Text] [Related]
2. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia. Braude AI; Ziegler EJ; Douglas H; McCutchan JA J Infect Dis; 1977 Aug; 136 Suppl():S167-73. PubMed ID: 330776 [TBL] [Abstract][Full Text] [Related]
3. Antiserum treatment of gram-negative bacteremia. Braude AI; Ziegler EJ; McCutchan JA Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528 [TBL] [Abstract][Full Text] [Related]
4. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067 [TBL] [Abstract][Full Text] [Related]
5. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. Ziegler EJ; McCutchan JA; Fierer J; Glauser MP; Sadoff JC; Douglas H; Braude AI N Engl J Med; 1982 Nov; 307(20):1225-30. PubMed ID: 6752708 [TBL] [Abstract][Full Text] [Related]
6. Antiserum against Escherichia coli J5: a re-evaluation of its in vitro and in vivo activity against heterologous gram-negative bacteria. Trautmann M; Hahn H Infection; 1985; 13(3):140-5. PubMed ID: 3897069 [TBL] [Abstract][Full Text] [Related]
7. Prevention of lethal pseudomonas bacteremia with epimerase-deficient E. coli antiserum. Ziegler EJ; McCutchan JA; Douglas H; Braude AI Trans Assoc Am Physicians; 1975; 88():101-8. PubMed ID: 772922 [TBL] [Abstract][Full Text] [Related]
9. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant. Ziegler EJ; Douglas H; Sherman JE; Davis CE; Braude AI J Immunol; 1973 Aug; 111(2):433-8. PubMed ID: 4577881 [No Abstract] [Full Text] [Related]
10. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis. Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833 [TBL] [Abstract][Full Text] [Related]
11. Cross-reactive antibody in immunity to colisepticemia in calves. Wickstrom ML; Gay CC; Hodgson JL; Widders PR; Schaeffer D; Lee R; Corbeil LB Vet Microbiol; 1987 Mar; 13(3):259-71. PubMed ID: 3310376 [TBL] [Abstract][Full Text] [Related]
12. Passive protection against heterologous gram-negative bacteria mediated by antiserum to epimeraseless Rc mutant of Salmonella minnesota. Konstantinov G; Karacholeva M; Eskenazy M; Ivanova R; Vassileva J; Naumova F; Tekelieva R; Strahilov D Ann Immunol (Paris); 1982; 133D(1):71-6. PubMed ID: 6760795 [TBL] [Abstract][Full Text] [Related]
14. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755 [TBL] [Abstract][Full Text] [Related]
15. Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region. Appelmelk BJ; Verwey-van Vught AM; Maaskant JJ; Schouten WF; Thijs LG; Maclaren DM Antonie Van Leeuwenhoek; 1986; 52(6):537-42. PubMed ID: 3545072 [TBL] [Abstract][Full Text] [Related]
16. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia. McCutchan JA; Wolf JL; Ziegler EJ; Braude AI Schweiz Med Wochenschr Suppl; 1983; 14():40-5. PubMed ID: 6361990 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine. Fenwick BW; Cullor JS; Osburn BI; Olander HJ Infect Immun; 1986 Aug; 53(2):298-304. PubMed ID: 3525407 [TBL] [Abstract][Full Text] [Related]
18. Treatment of gram-negative bacteremia with antiserum to core glycolipid II. A controlled trial of antiserum in patients with bacteremia. McCutchan JA; Ziegler EJ; Braude AI Eur J Cancer (1965); 1979; 15 Suppl():77-80. PubMed ID: 397064 [No Abstract] [Full Text] [Related]